United Therapeutics Corp
NASDAQ:UTHR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
United Therapeutics Corp
NASDAQ:UTHR
|
US |
|
L
|
Lumentum Holdings Inc
F:LU2
|
US |
Wall St Price Targets
UTHR Price Targets Summary
United Therapeutics Corp
According to Wall Street analysts, the average 1-year price target for
UTHR is 681.38 USD with a low forecast of 521.16 USD and a high forecast of 787.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UTHR's stock price target?
Price Target
681.38
USD
According to Wall Street analysts, the average 1-year price target for
UTHR is 681.38 USD with a low forecast of 521.16 USD and a high forecast of 787.5 USD.
What is the Revenue forecast for United Therapeutics Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for United Therapeutics Corp?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 6 years is 15%.
What is the Operating Income forecast for United Therapeutics Corp?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 14%.
What is the Pre-Tax Income forecast for United Therapeutics Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 11%.
What is the Net Income forecast for United Therapeutics Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 11%.